Status:
RECRUITING
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma
Lead Sponsor:
Fundacion Clinic per a la Recerca Biomédica
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
University Hospital Tuebingen
Conditions:
Congenital Melanocytic Nevi
Melanoma, Skin
Eligibility:
All Genders
Brief Summary
The primary objective of this study is to identify the molecular identity profiles of all cellular states that characterize the progression from benign nevi to malignant melanoma in CAYA patients with...
Detailed Description
NevustoMel is an international multicentric retrospective cohort study with molecular and experimental design. It will involve the genomic characterization of cell-free DNA and affected tissues from p...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Congenital nevus with estimated size of 20 cm
- Be over 18 years of age
- Exclusion criteria:
- No available biological material
- Not having signed the informed consent
Exclusion
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06605417
Start Date
January 1 2024
End Date
November 30 2026
Last Update
February 27 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
French National Institute of Health and Medical Research
Marseille, France
2
Hospital Clínic de Barcelona (Dermatology service)
Barcelona, Spain